Individual Jena Bioscience Screen Condition, 10 ml (Classic, Basic, Membrane, Cryo, Kinase, PEG/Salt) Indicate screen and condition # when placing the order |
M-CS-IND-10ML |
MiTeGen |
10 ml |
EUR 116 |
Description: Individual Jena Bioscience Screen Condition, 10 ml (Classic, Basic, Membrane, Cryo, Kinase, PEG/Salt) Indicate screen and condition # when placing the order |
Human IgG antibody Laboratories manufactures the clk-n002-10 (jena bioscience reagents distributed by Genprice. The Clk-N002-10 (Jena Bioscience reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Jena Bioscience GmbH. Other Clk-N002-10 products are available in stock. Specificity: Clk-N002-10 Category: (Jena Group: Bioscience
Bioscience information
Spike S1 (K417T, E484K, N501Y), Avi-His-Tag, Biotin-Labeled (SARS-CoV-2) |
101082-2 |
BPS Bioscience |
50 µg |
EUR 435 |
Description: Recombinant SARS-CoV-2 Spike protein S1 subunit, encompassing amino acids 16-685. This protein contains three mutations of interest K417T, E484K and N501Y (found in the RBD domain of some variants of concern). The construct contains a C-terminal Avi-Tag™ followed by a His-tag (6xHis). The protein was enzymatically biotinylated using the Avi-Tag™ and affinity purified. |
Spike S1 (K417T, E484K, N501Y), Avi-His-Tag, Biotin-Labeled (SARS-CoV-2) |
101082-3 |
BPS Bioscience |
500 µg_x000D_ |
EUR 3800 |
Description: Recombinant SARS-CoV-2 Spike protein S1 subunit, encompassing amino acids 16-685. This protein contains three mutations of interest K417T, E484K and N501Y (found in the RBD domain of some variants of concern). The construct contains a C-terminal Avi-Tag™ followed by a His-tag (6xHis). The protein was enzymatically biotinylated using the Avi-Tag™ and affinity purified. |
Tau-383 (N352H) Protein |
90310 |
BPS Bioscience |
20 µg |
EUR 270 |
Description: Human Tau-383 (N352H) Protein, GenBank Accession No. P10636-6, full length, expressed in an E. coli expression system. MW = 51 kDa. |
Tau-441 (N279K) Protein |
90347 |
BPS Bioscience |
20 µg |
EUR 270 |
Description: Human Tau-441 with a N279K mutation, GenBank Accession No. P10636-8, full length, expressed in an E. coli expression system. MW = 64 kDa. |
PI3 Kinase [p110α (N345K)/p85α], His-Tag |
40646 |
BPS Bioscience |
10 µg |
EUR 465 |
Description: Complex of recombinant full-length human p110α (GenBank Accession No. NM_006218.2) with N345K mutation and N-terminal His-Tag, and recombinant full length, human p85α (GenBank Accession No. NM_181523), no tag. Co-expressed in Sf9 cells in a Baculovirus expression system. p110α (N345K) MW=111 kDa, p85α MW=86 kDa. |
FGFR3 (N540K) His-Tag (Dephosphorylated) |
100907 |
BPS Bioscience |
10 µg |
EUR 375 |
Description: Dephosphorylated recombinant FGFR3 (Fibroblast Growth Factor Receptor 3) encompassing a.a. 397-806, with an N540K mutation and an N-terminal His-Tag. This protein was co-expressed with PTP1B for dephosphorylation. Phosphorylation level <5%. |
Spike Trimer (S1+S2) (K417T, E484K, N501Y), His- Tag (SARS-CoV-2) |
100988-1 |
BPS Bioscience |
100 µg |
EUR 320 |
Description: Recombinant SARS-CoV-2 Spike protein in its homotrimeric form, containing S1+S2 subunits and encompassing amino acids 16-1213. This protein contains three mutations: K417T, E484K and N501Y that have been found in emerging SARS-CoV-2 Variants of Concern and may lead to higher transmissibility and infectivity. This mutant Spike Trimer will be useful for structure-function studies, testing of neutralizing antibodies, or antibody and drug screening. The construct also contains a C-terminal His-tag. Note that the expected MW of the S1+S2 monomer is 136kDa but migrates at a higher MW in SDS-PAGE due to glycosylation. The recombinant protein is ?90% pure following affinity purification. |
Spike Trimer (S1+S2) (K417T, E484K, N501Y), His- Tag (SARS-CoV-2) |
100988-2 |
BPS Bioscience |
1 mg |
EUR 2850 |
Description: Recombinant SARS-CoV-2 Spike protein in its homotrimeric form, containing S1+S2 subunits and encompassing amino acids 16-1213. This protein contains three mutations: K417T, E484K and N501Y that have been found in emerging SARS-CoV-2 Variants of Concern and may lead to higher transmissibility and infectivity. This mutant Spike Trimer will be useful for structure-function studies, testing of neutralizing antibodies, or antibody and drug screening. _x000D_The construct also contains a C-terminal His-tag. Note that the expected MW of the S1+S2 monomer is 136kDa but migrates at a higher MW in SDS-PAGE due to glycosylation. The recombinant protein is ?90% pure following affinity purification. |
Spike S1 (K417T, E484K, N501Y), Avi-His-Tag (SARS-CoV-2) |
101081-1 |
BPS Bioscience |
100 µg |
EUR 320 |
Description: Recombinant SARS-CoV-2 Spike protein, S1 subunit encompassing amino acids 16-685. This protein contains three mutations of interest K417T, E484K and N501Y, in addition to 682RRAR685>A. The construct also contains a C-terminal Avi-Tag™ followed by a His-tag (6xHis). The recombinant protein was affinity purified. |
Spike S1 (K417T, E484K, N501Y), Avi-His-Tag (SARS-CoV-2) |
101081-2 |
BPS Bioscience |
1 mg |
EUR 2850 |
Description: Recombinant SARS-CoV-2 Spike protein, S1 subunit encompassing amino acids 16-685. This protein contains three mutations of interest K417T, E484K and N501Y, in addition to 682RRAR685>A. The construct also contains a C-terminal Avi-Tag™ followed by a His-tag (6xHis). The recombinant protein was affinity purified. |
Spike S1 RBD (K417T, E484K, N501Y), Avi-His-Tag (SARS-CoV-2) |
100993-1 |
BPS Bioscience |
100 µg |
EUR 335 |
Description: Recombinant SARS-CoV-2 Spike protein, RBD (Receptor Binding Domain) encompassing amino acids 319-541. This protein corresponds to the RBD of SARS-CoV-2 Variant P.1, originally discovered in Brazil, and contains the three mutations K417T, E484K and N501Y. It also contains a C-terminal Avi-Tag™ and a C-terminal His-tag. The recombinant protein is ≥90% pure following affinity purification. |
Spike S1 RBD (K417T, E484K, N501Y), Avi-His-Tag (SARS-CoV-2) |
100993-2 |
BPS Bioscience |
1 mg |
EUR 2995 |
Description: Recombinant SARS-CoV-2 Spike protein, RBD (Receptor Binding Domain) encompassing amino acids 319-541. This protein corresponds to the RBD of SARS-CoV-2 Variant P.1, originally discovered in Brazil, and contains the three mutations K417T, E484K and N501Y. It also contains a C-terminal Avi-Tag™ and a C-terminal His-tag. The recombinant protein is ≥90% pure following affinity purification. |
Spike S1 (K417T, E484K, N501Y) (SARS-CoV-2): ACE2 TR-FRET Assay Kit |
78293 |
BPS Bioscience |
384 rxns. |
EUR 930 |
Description: The Spike S1 (K417T, E484K, N501Y) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 (K417T, E484K, N501Y) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET). |
Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter) |
78143-1 |
BPS Bioscience |
100 µl |
EUR 835 |
Description: The Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 Variant Spike (Genbank Accession #QHD43416.1 with mutations K417T, E484K, and N501Y) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by a CMV promoter, therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (SARS-CoV-2, K417T, E484K, N501Y) pseudotyped lentivirus can be used to measure the activity of neutralizing antibody against SARS-CoV-2 K417T, E484K, N501Y variant in intact cells using a Biosafety Level 2 facility._x000D_ |
Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter) |
78143-2 |
BPS Bioscience |
500 µl x 2 |
EUR 4195 |
Description: The Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 Variant Spike (Genbank Accession #QHD43416.1 with mutations K417T, E484K, and N501Y) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by a CMV promoter, therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (SARS-CoV-2, K417T, E484K, N501Y) pseudotyped lentivirus can be used to measure the activity of neutralizing antibody against SARS-CoV-2 K417T, E484K, N501Y variant in intact cells using a Biosafety Level 2 facility._x000D_ |
Spike RBD (B.1.1.7 Variant) (N501Y) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit |
78133 |
BPS Bioscience |
96 rxns. |
EUR 995 |
Description: The Spike RBD (SARS-CoV-2) UK variant (N501Y):ACE2 Inhibitor Screening Colorimetric Assay Kit is designed for screening and profiling inhibitors of the interaction of ACE2 with the UK variant (N501Y) of the SARS-CoV-2 Spike RBD protein. The key to this kit is the high sensitivity of detection of ACE2-Biotin protein by Streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, Spike RBD protein UK variant is coated on a 96-well transparent plate. Next, ACE2-Biotin is incubated with Spike RBD UK variant on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce color, which can then be measured using a UV/Vis spectrophotometer microplate reader. |